Insights From the Use in Clinical Practice of Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome Affecting the Native Kidneys: An Analysis of 19 Cases
- 1 January 2014
- journal article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 63 (1), 40-48
- https://doi.org/10.1053/j.ajkd.2013.07.011
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic SyndromeNew England Journal of Medicine, 2013
- Complement Genes Strongly Predict Recurrence and Graft Outcome in Adult Renal Transplant Recipients with Atypical Hemolytic and Uremic SyndromeAmerican Journal of Transplantation, 2013
- Thrombocytopenia is not mandatory to diagnose haemolytic and uremic syndromeBMC Nephrology, 2013
- Eculizumab for Atypical Hemolytic Uremic Syndrome Recurrence in Renal TransplantationAmerican Journal of Transplantation, 2012
- Cancer-Related Microangiopathic Hemolytic AnemiaMedicine, 2012
- Relative Role of Genetic Complement Abnormalities in Sporadic and Familial aHUS and Their Impact on Clinical PhenotypeClinical Journal of the American Society of Nephrology, 2010
- Anti-Factor H Autoantibody–Associated Hemolytic Uremic Syndrome: Review of Literature of the Autoimmune Form of HUSSeminars in Thrombosis and Hemostasis, 2010
- Pregnancy-Associated Hemolytic Uremic Syndrome Revisited in the Era of Complement Gene MutationsJournal of the American Society of Nephrology, 2010
- VEGF Inhibition and Renal Thrombotic MicroangiopathyNew England Journal of Medicine, 2008
- Does hemolytic uremic syndrome differ from thrombotic thrombocytopenic purpura?Nature Clinical Practice Nephrology, 2007